92 related articles for article (PubMed ID: 24683815)
1. [MIF in head and neck cancer: a new therapeutic target ?].
Lechien JR; Kindt N; Costa Pde A; Chantrain G; Preillon J; Laurent G; Saussez S
Rev Laryngol Otol Rhinol (Bord); 2013; 134(2):67-74. PubMed ID: 24683815
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
3. Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Lechien JR; Nassri A; Kindt N; Brown DN; Journe F; Saussez S
Head Neck; 2017 Dec; 39(12):2573-2584. PubMed ID: 28963807
[TBL] [Abstract][Full Text] [Related]
4. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
[TBL] [Abstract][Full Text] [Related]
5. The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors.
Bach JP; Deuster O; Balzer-Geldsetzer M; Meyer B; Dodel R; Bacher M
Cancer; 2009 May; 115(10):2031-40. PubMed ID: 19326434
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Kindt N; Laurent G; Nonclercq D; Journé F; Ghanem G; Duvillier H; Gabius HJ; Lechien J; Saussez S
Int J Oncol; 2013 Jul; 43(1):185-93. PubMed ID: 23677331
[TBL] [Abstract][Full Text] [Related]
7. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
8. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
Shin HN; Moon HH; Ku JL
Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor and its role in autoimmune diseases.
Denkinger CM; Metz C; Fingerle-Rowson G; Denkinger MD; Forsthuber T
Arch Immunol Ther Exp (Warsz); 2004; 52(6):389-400. PubMed ID: 15577740
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
11. Current developments of macrophage migration inhibitory factor (MIF) inhibitors.
Xu L; Li Y; Sun H; Zhen X; Qiao C; Tian S; Hou T
Drug Discov Today; 2013 Jun; 18(11-12):592-600. PubMed ID: 23466524
[TBL] [Abstract][Full Text] [Related]
12. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
Santos LL; Morand EF
Wien Med Wochenschr; 2006 Jan; 156(1-2):11-8. PubMed ID: 16465610
[TBL] [Abstract][Full Text] [Related]
13. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A
J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234
[TBL] [Abstract][Full Text] [Related]
14. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J
Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor involvement in breast cancer (Review).
Richard V; Kindt N; Saussez S
Int J Oncol; 2015 Nov; 47(5):1627-33. PubMed ID: 26412712
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor increases cell motility and up-regulates αvβ3 integrin in human chondrosarcoma cells.
Lee CY; Su MJ; Huang CY; Chen MY; Hsu HC; Lin CY; Tang CH
J Cell Biochem; 2012 May; 113(5):1590-8. PubMed ID: 22174124
[TBL] [Abstract][Full Text] [Related]
17. Tumor growth-promoting properties of macrophage migration inhibitory factor.
Bifulco C; McDaniel K; Leng L; Bucala R
Curr Pharm Des; 2008; 14(36):3790-801. PubMed ID: 19128232
[TBL] [Abstract][Full Text] [Related]
18. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor.
Morand EF
Intern Med J; 2005 Jul; 35(7):419-26. PubMed ID: 15958113
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
Bacher M; Schrader J; Thompson N; Kuschela K; Gemsa D; Waeber G; Schlegel J
Am J Pathol; 2003 Jan; 162(1):11-7. PubMed ID: 12507885
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
Li Y; Lu C; Xing G; Zhu Y; He F
Exp Cell Res; 2004 Nov; 300(2):379-87. PubMed ID: 15475002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
